Italfarmaco   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Milan Italy (1938)

Organization Overview

First Clinical Trial
2003
NCT00951574
First Marketed Drug
2018
riluzole (rilutek)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Italfarmaco | Italfarmaco S.A | Italfarmaco S.p.A. | ITALFARMACO SPA